Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response
出版年份 2016 全文链接
标题
Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response
作者
关键词
-
出版物
Cancers
Volume 8, Issue 12, Pages 107
出版商
MDPI AG
发表日期
2016-11-29
DOI
10.3390/cancers8120107
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase
- (2016) Stanley G. Kimani et al. Cell Communication and Signaling
- Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease and cancer
- (2016) R B Birge et al. CELL DEATH AND DIFFERENTIATION
- Efferocytosis
- (2016) Sushil Kumar et al. CURRENT BIOLOGY
- Antibody-mediated neutralization of autocrine Gas6 inhibits the growth of pancreatic ductal adenocarcinoma tumorsin vivo
- (2016) Gordon Moody et al. INTERNATIONAL JOURNAL OF CANCER
- Development and characterization of a human microglia cell model of HIV-1 infection
- (2016) Pratima Rawat et al. JOURNAL OF NEUROVIROLOGY
- MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation
- (2016) Bishuang Cai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TAM Receptor Signaling in Immune Homeostasis
- (2015) Carla V. Rothlin et al. Annual Review of Immunology
- Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis
- (2015) Amanda Kirane et al. CANCER RESEARCH
- Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia
- (2015) Alisa B. Lee-Sherick et al. Oncotarget
- Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging
- (2015) Sandra Santulli-Marotto et al. PLoS One
- MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme
- (2015) Kristina H. Knubel et al. Oncotarget
- Axl as a mediator of cellular growth and survival
- (2015) Haley Axelrod et al. Oncotarget
- Increased Exposure of Phosphatidylethanolamine on the Surface of Tumor Vascular Endothelium
- (2015) Jason H. Stafford et al. NEOPLASIA
- AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs
- (2014) C. Wilson et al. CANCER RESEARCH
- Cleavage of Mer Tyrosine Kinase (MerTK) from the Cell Surface Contributes to the Regulation of Retinal Phagocytosis
- (2014) Ah-Lai Law et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation
- (2014) Wen-I Tsou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution
- (2014) Jamie C. Stanford et al. JOURNAL OF CLINICAL INVESTIGATION
- UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
- (2014) Weihe Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
- (2014) Magdalena Paolino et al. NATURE
- An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis
- (2014) Mihalis S Kariolis et al. Nature Chemical Biology
- Diversification of TAM receptor tyrosine kinase function
- (2014) Anna Zagórska et al. NATURE IMMUNOLOGY
- Liver-Specific γ-Glutamyl Carboxylase-Deficient Mice Display Bleeding Diathesis and Short Life Span
- (2014) Kotaro Azuma et al. PLoS One
- Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
- (2014) Erinn B. Rankin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
- (2014) Erin D Lew et al. eLife
- Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity
- (2014) Stanley Gititu Kimani et al. Frontiers in Immunology
- Gas6 gains entry into the coagulation cascade
- (2013) J. H. Foley et al. BLOOD
- Inhibitory role of Gas6 in intestinal tumorigenesis
- (2013) Reiko Akitake-Kawano et al. CARCINOGENESIS
- T Cell-Derived Protein S Engages TAM Receptor Signaling in Dendritic Cells to Control the Magnitude of the Immune Response
- (2013) Eugenio A. Carrera Silva et al. IMMUNITY
- MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
- (2013) Rebecca S. Cook et al. JOURNAL OF CLINICAL INVESTIGATION
- MERTK receptor tyrosine kinase is a therapeutic target in melanoma
- (2013) Jennifer Schlegel et al. JOURNAL OF CLINICAL INVESTIGATION
- UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic LeukemiaIn VitroandIn Vivo
- (2013) Sandra Christoph et al. MOLECULAR CANCER THERAPEUTICS
- Identification of a unique TGF-β–dependent molecular and functional signature in microglia
- (2013) Oleg Butovsky et al. NATURE NEUROSCIENCE
- Highly Specific PET Imaging of Prostate Tumors in Mice with an Iodine-124-Labeled Antibody Fragment That Targets Phosphatidylserine
- (2013) Jason H. Stafford et al. PLoS One
- Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer
- (2013) L. Bosurgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biology of the TAM Receptors
- (2013) G. Lemke Cold Spring Harbor Perspectives in Biology
- Clearing the Dead: Apoptotic Cell Sensing, Recognition, Engulfment, and Digestion
- (2013) A. Hochreiter-Hufford et al. Cold Spring Harbor Perspectives in Biology
- Vascular Gas6 contributes to thrombogenesis and promotes tissue factor up-regulation after vessel injury in mice
- (2012) R. S. Robins et al. BLOOD
- Inhibitors of the TAM subfamily of tyrosine kinases: Synthesis and biological evaluation
- (2012) Rosa M. Suárez et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- MET: a promising anticancer therapeutic target
- (2012) Solange Peters et al. Nature Reviews Clinical Oncology
- Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer
- (2012) R M A Linger et al. ONCOGENE
- Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA
- (2011) Mark Mackiewicz et al. BREAST CANCER RESEARCH AND TREATMENT
- Shedding of the Mer Tyrosine Kinase Receptor Is Mediated by ADAM17 Protein through a Pathway Involving Reactive Oxygen Species, Protein Kinase Cδ, and p38 Mitogen-activated Protein Kinase (MAPK)
- (2011) Edward Thorp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-3 is a new MerTK-specific eat-me signal
- (2011) Nora B. Caberoy et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
- (2011) G Mudduluru et al. ONCOGENE
- Differentiation and Glucocorticoid Regulated Apopto-Phagocytic Gene Expression Patterns in Human Macrophages. Role of Mertk in Enhanced Phagocytosis
- (2011) Gábor Zahuczky et al. PLoS One
- Macrophages give Gas(6) to cancer
- (2010) A. Sica BLOOD
- R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
- (2010) S. J. Holland et al. CANCER RESEARCH
- Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis
- (2010) Nora B Caberoy et al. EMBO JOURNAL
- Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury
- (2010) Laura Llacuna et al. HEPATOLOGY
- Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization
- (2010) J. M. E. M. COSEMANS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Up-Regulation of Soluble Axl and Mer Receptor Tyrosine Kinases Negatively Correlates with Gas6 in Established Multiple Sclerosis Lesions
- (2009) Jason G. Weinger et al. AMERICAN JOURNAL OF PATHOLOGY
- Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6
- (2009) S. Loges et al. BLOOD
- Identification of tubby and tubby-like protein 1 as eat-me signals by phage display
- (2009) Nora B. Caberoy et al. EXPERIMENTAL CELL RESEARCH
- TAM receptors and the regulation of erythropoiesis in mice
- (2009) H. Tang et al. HAEMATOLOGICA
- Glucocorticoids Induce Protein S-Dependent Phagocytosis of Apoptotic Neutrophils by Human Macrophages
- (2009) A. McColl et al. JOURNAL OF IMMUNOLOGY
- Discovery ofN-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily
- (2009) Gretchen M. Schroeder et al. JOURNAL OF MEDICINAL CHEMISTRY
- Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
- (2009) C. Gjerdrum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gas6-mediated signaling is dependent on the engagement of its gamma-carboxyglutamic acid domain with phosphatidylserine
- (2008) Isabelle Rajotte et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development
- (2008) I.-K. Park et al. BLOOD
- Axl and Growth Arrest Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme
- (2008) M. Hutterer et al. CLINICAL CANCER RESEARCH
- Role of thePROS1gene in thrombosis: lessons and controversies
- (2008) Mary J Heeb Expert Review of Hematology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started